Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition

INTRODUCTION: Synergistic effects have been discussed for tyrosine kinase (TKI) and immune checkpoint inhibitors (ICI). Primary resistance to TKI might disturb subsequent ICI effectiveness. The objective was to investigate, if primary resistance to 1st line TKI monotherapy predicts response to ICI i...

Descripción completa

Detalles Bibliográficos
Autores principales: Börner, J. H., Neuberger, S., Juengel, E., Ziewers, S., Dotzauer, R., Sparwasser, P., Höfner, T., Tsaur, I., Haferkamp, A., Mager, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517909/
https://www.ncbi.nlm.nih.gov/pubmed/37740836
http://dx.doi.org/10.1007/s12672-023-00791-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517909/
https://www.ncbi.nlm.nih.gov/pubmed/37740836
http://dx.doi.org/10.1007/s12672-023-00791-3

Ejemplares similares